Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Innate Pharma
  6. News
  7. All News
    IPH   FR0010331421

INNATE PHARMA

(IPH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about INNATE PHARMA
07/16INNATE PHARMA : Corporate Presentation | July 2021
PU
07/06GLOBAL MARKETS LIVE : Facebook, AngloGold, Didi, Weibo, Daimler...
07/06INNATE PHARMA : Update on Avdoralimab Phase 2 Force Trial in COVID-19 Patients W..
PU
07/06INNATE PHARMA S A : Trial of Avdoralimab for COVID-19 Did Not Meet Goals; To Sto..
MT
07/06INNATE PHARMA : to Stop Evaluating Antibody for COVID-19 After Mid-Stage Failure
MT
07/06Update on Avdoralimab Phase 2 Force Trial in COVID-19 Patients With Severe Pn..
GL
07/06Innate Pharma SA Announces Update on Avdoralimab Phase 2 Force Trial in COVID..
CI
06/22RESULTS PRESENTED AT 16TH INTERNATIO : 00 p.m. CEST / 8:00 a.m. EDT (Form 6-K)
PU
06/22INNATE PHARMA : presents preliminary data from TELLOMAK trial showing clinical r..
GL
06/22Innate Pharma Presents Preliminary Data from TELLOMAK Trial Showing Clinical ..
CI
06/16GLOBAL MARKETS LIVE : Oracle, General Motors, Credit Suisse, Sony, Made.com...
06/16INNATE PHARMA : Company to highlight lacutamab data in mycosis fungoides and sha..
PU
06/16Innate Pharma to Host Virtual Investor Event to Highlight Progress Against Co..
GL
06/10INNATE PHARMA : Presents New Data on Next-Generation NK Cell Engager Platform at..
PU
06/10Innate Pharma Presents New Data on Next-Generation NK Cell Engager Platform a..
CI
06/10Innate Pharma Molecule Shows Anti-Tumor Effect in Preclinical Studies
MT
06/10Innate Pharma Presents New Data on Next-Generation NK Cell Engager Platform a..
GL
06/09INNATE PHARMA : New Lacutamab Data From Tellomak Trial to be Showcased in Oral P..
PU
06/09New Lacutamab Data from TELLOMAK Trial to be Showcased in Oral Presentation a..
GL
06/09Innate Pharma S.A. Announces New Lacutamab Data from Tellomak Trial in Oral P..
CI
06/03INNATE PHARMA : Assemblee Generale Mixte
PU
05/31NHTHERAGUIX : NH TherAguix and the CHU Grenoble-Alpes announce the publication o..
DJ
05/28INNATE PHARMA : Outcome of Innate Pharma's Annual General Meeting (Form 6-K)
PU
05/28INNATE PHARMA : Outcome of Innate Pharma's Annual General Meeting
PU
05/28INNATE PHARMA : Outcome of Innate Pharma's Annual General Meeting
GL
05/28Marcus Schindler Decides Not to Seek Re-Election as Member of Supervisory Boa..
CI
05/20SEZARY SYNDROME PIPELINE : Emerging Therapies and Key pharma players involved by..
AQ
05/19INNATE PHARMA : Erratum (English Version)
PU
05/14INNATE PHARMA : Virtual 2021 Annual General Meeting (Form 6-K)
PU
05/12INNATE PHARMA : First Quarter 2021 Report (Form 6-K)
PU
05/12Innate Pharma Virtual 2021 Annual General Meeting
GL
05/11INNATE PHARMA : Corporate Presentation | May 2021
PU
05/11Innate Pharma First Quarter 2021 Report
GL
05/07INNATE PHARMA : IPH 12.20 Rapport spécial AGE 05 2021 (27 résolution) Stock opti..
PU
05/07INNATE PHARMA : IPH 12.20 Rapport spécial AGE 05 2021 (28 résolution) AGA (Dir r..
PU
05/07INNATE PHARMA : IPH 12.20 Rapport spécial AGE 05 2021 (29 résolution) AGA (Perf ..
PU
05/07INNATE PHARMA : IPH 12.20 Rapport spécial AGE 05 2021 (30 résolution) AGA (Perf ..
PU
05/07INNATE PHARMA : IPH 12.20 Rapport spécial AGE 05 2021 (31 résolution) PEE.pdf
PU
05/07INNATE PHARMA : IPH 12.20 Rapport spécial AGE 05 2021 (32 résolution) Réduction...
PU
05/07INNATE PHARMA : IPH 12.20 Rapport spécial AGE 05 2021 Conversion actions de préf..
PU
05/04INNATE PHARMA : Announces Conference Call and Webcast for 2021 First Quarter Bus..
GL
05/03INNATE PHARMA : 2021 Convening Notice
PU
04/28INNATE PHARMA : Files its 2020 Universal Registration Document (Document d'Enreg..
AQ
04/28Innate Pharma Files Its 2020 Universal Registration Document (Document D'enre..
GL
04/22INNATE PHARMA : 2021 AGM Voting Form
PU
04/21INNATE PHARMA : to Hold its Annual General Meeting of Shareholders on May 28, 20..
GL
03/18INNATE PHARMA S A : 2020 Loss Widens, Revenue Declines
MT
03/18INNATE PHARMA : reports Full Year 2020 financial results and business update
AQ
03/18Innate Pharma Reports Full Year 2020 Financial(1) Results and Business Update
GL
03/18Innate Pharma S.A. Reports Earnings Results for the Full Year Ended December ..
CI
03/16INNATE PHARMA : Annual financial announcement
PU
03/16INNATE PHARMA : announces conference call and webcast for Full Year 2020 financi..
GL
03/16Innate Pharma Announces Conference Call and Webcast for Full Year 2020 Financ..
GL
02/17INNATE PHARMA : to participate in the 10th Annual SVB Leerink Global Healthcare ..
GL
02/09INNATE PHARMA : advances lacutamab clinical development program
GL
02/09Innate Pharma S.A. Advances Lacutamab Clinical Development Program
CI
02/03Innate Pharma to Host Key Opinion Leader Discussion on the Potential Role of ..
GL
02/03INNATE PHARMA : to host key opinion leader discussion on the potential role of l..
GL
01/05SECTOR UPDATE : Health Care Stocks Mixed Premarket Tuesday
MT
01/05SANOFI : Innate Pharma Shares Rise as Sanofi Selects its Anti-Tumor Drug Candida..
MT
01/05INNATE PHARMA : Sanofi Selects Innate's First NK Cell Engager as Anti-Tumor Drug..
MT
01/05Innate's First NK Cell Engager Selected by Sanofi as Drug Candidate for Devel..
GL
01/05INNATE PHARMA : first NK cell engager selected by Sanofi as drug candidate for d..
GL
01/05Innate's First NK Cell Engager Selected by Sanofi as Drug Candidate for Devel..
CI
01/04Innate Pharma to Participate in Upcoming Investor Conferences
GL
01/04INNATE PHARMA : to participate in upcoming investor conferences
GL
2020INNATE PHARMA S A : SVB Leerink Downgrades Innate Pharma to Market Perform From ..
MT
2020INNATE PHARMA S A : HC Wainwright Adjusts Innate Pharma's Price Target to $11.50..
MT
2020INNATE PHARMA : to return US and EU Lumoxiti commercialization rights to AstraZe..
AQ
2020MIDDAY REPORT : Wall Street Weaker Midday On Stimulus Woes
MT
2020SECTOR UPDATE : Health Care Stocks Trade Lower Premarket Friday
MT
2020INNATE PHARMA S A : to Give Up License to AstraZeneca's Leukemia Drug Due to Low..
MT
2020ASTRAZENECA : Innate Pharma To Return Immunotoxin's Commercialization Rights In ..
MT
2020Innate Pharma to Return US and EU Lumoxiti Commercialization Rights to AstraZ..
GL
2020INNATE PHARMA : áInnate Pharma to return US and EU Lumoxiti commercialization ri..
GL
1  2  3  4  5  6  7  8  9Next
Upcoming event on INNATE PHARMA
Upcoming sector events